Cited by 192Advanced Drug Delivery SystemsAdvancements in Transdermal Drug DeliveryNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress

Open access

Pangeni, Rudra, Sharma, Shrestha, Mustafa, Gulam, Ali, Javed, Baboota, Sanjula·2014·Nanotechnology

Open this paper in CoChat — free account Open PDF

Abstract

Resveratrol, a potent natural antioxidant, possesses a wide range of pharmacological activities, but its oral bioavailability is very low due to its extensive hepatic and presystemic metabolism. The aim of the present study was to formulate a kinetically stable nanoemulsion (o/w) using vitamin E:sefsol (1:1) as the oil phase, Tween 80 as the surfactant and Transcutol P as the co-surfactant for the better management of Parkinson's disease. The nanoemulsion was prepared by a spontaneous emulsification method, followed by high-pressure homogenization. Ternary phase diagrams were constructed to locate the area of nanoemulsion. The prepared formulations were studied for globule size, zeta potential, refractive index, viscosity, surface morphology and in vitro and ex vivo release. The homogenized formulation, which contained 150 mg ml(-1) of resveratrol, showed spherical globules with an average globule diameter of 102 ± 1.46 nm, a least poly dispersity index of 0.158 ± 0.02 and optimal zeta potential values of -35 ± 0.02. The cumulative percentage drug release for the pre-homogenized resveratrol suspension, pre-homogenized nanoemulsion and post-homogenized nanoemulsion were 24.18 ± 2.30%, 54.32 ± 0.95% and 88.57 ± 1.92%, respectively, after 24 h. The ex vivo release also showed the cumulative percentage drug release of 85.48 ± 1.34% at 24 h. The antioxidant activity determined by using a DPPH assay showed high scavenging efficiency for the optimized formulation. Pharmacokinetic studies showed the higher concentration of the drug in the brain (brain/blood ratio: 2.86 ± 0.70) following intranasal administration of the optimized nanoemulsion. Histopathological studies showed decreased degenerative changes in the resveratrol nanoemulsion administered groups. The levels of GSH and SOD were significantly higher, and the level of MDA was significantly lower in the resveratrol nanoemulsion treated group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1088/0957-4484/25/48/485102

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels
Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892
Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent
Sedlak, J., & Lindsay, R. H. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90092-4 · Cited by 8,092
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,893
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,409
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Neuropsychopharmacology: The Fifth Generation of Progress
Sagduyu, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,023
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 487
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Effect of sulfhydryl reagents on peroxidation in microsomes
Utley, H. G., Bernheim, F., & Hochstein, P. E. (1967) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(67)90273-1 · Cited by 446
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F. J., Wu, Q., Lu, Y., Gong, Q., & Shi, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384

Show all 32 references

Research works printed but not linked: 2

Ahmad M P, 2012, J. Clin. Diagn. Res., 6, 542
Shadab M, 2014, Expert Opin. Drug Deliv., 11, 1

Sorted by citations

Items 101–191 of 191

Lipid Nanoparticles Improve the Uptake of α-Asarone Into the Brain Parenchyma: Formulation, Characterization, In Vivo Pharmacokinetics, and Brain Delivery
Ramalingam, P., Ganesan, P., Prabakaran, D. S., Gupta, P. K., Jonnalagadda, S., Karthivashan, G., Revuri, V., Sivalingam, K., Sodha, S., Choi, D., et al. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01832-8 · Cited by 19
Neuroprotection by resveratrol: A review on brain delivery strategies for Alzheimer's and Parkinson's disease
Chinraj, V., & Sureshkumar, R. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120701 · Cited by 24
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Kanojia, N., Thapa, K., Kaur, G., Sharma, A., Puri, V., & Verma, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104074 · Cited by 19
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease
Yang, K., Lv, Z., Wen, Z., Lai, G., Zheng, C., Qi, F., Zhao, C., Hu, K., Chen, X., Fu, F., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1468850 · Cited by 19
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 20
FORMULATION AND EVALUATION OF CARICA PAPAYA NANOEMULSION FOR TREATMENT OF DENGUE AND THROMBOCYTOPENIA
Mandal, S., Jaiswal, V., Sagar, M. K., & Kumar, S. (2021) · PLANT ARCHIVES · doi:10.51470/plantarchives.2021.v21.no1.179 · Cited by 18
Mechanistic Role of Methanolic Extract of Taraxacum officinale Roots as Cardioprotective Against Ischemia–Reperfusion Injury-Induced Myocardial Infarction in Rats
Sharma, M., Pal, P., Pottoo, F. H., & Kumar, S. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04282-z · Cited by 16
Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases
Tsakiri, M., Tsichlis, I., Zivko, C., Demetzos, C., & Mahairaki, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030350 · Cited by 19
Efficient nose-to-brain delivery of chitosan-coated resveratrol nanoemulsion in rats: Formulation optimized using D-optimal mixture design
Yadav, K. S., Nijhawan, H. P., Nirale, P., Singhal, D., & Soni, G. (2025) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2025.2483899 · Cited by 16
Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer's disease treatment
Li, H., Shen, X., Zhang, B., Li, Y., Alexander, C., Harvey, P., & Zhu, Z. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00148j · Cited by 18
Designing lisuride intranasal nanocarrier system for reduction of oxidative damage with enhanced dopamine level in brain for Parkinsonism
Kumar, S., Gupta, S. K., & Pahwa, R. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.030 · Cited by 15
Research progress on intranasal treatment for Parkinson's disease
Wen, P., & Ren, C. (2024) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.42 · Cited by 18
Optimizing rosemary oil nanoemulsion loaded with nelfinavir and epigallocatechin gallate: A Design Expert® endorsed approach for enhanced neuroAIDS management
Verma, K., Chandane-Tak, M., Gaikwad, S., Mukherjee, A., & Kumar, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135885 · Cited by 15
Evaluating the Potential of Portulaca oleracea L. for Parkinson’s Disease Treatment Using a Drosophila Model with dUCH-Knockdown
Truong, H. K. T., Huynh, M. A., Dung, V. M., & Thảo, Đ. T. P. (2019) · Parkinson s Disease · doi:10.1155/2019/1818259 · Cited by 15
Nanocarriers for Resveratrol Delivery
Arora, D., & Jaglan, S. (2017) · Sustainable agriculture reviews · doi:10.1007/978-3-319-58496-6_5 · Cited by 15
VvHY5 and VvBEE1 antagonistically control resveratrol biosynthesis to mitigate high light‐induced damage in grapevine
Ali, Z., Sun, Y., Ma, Z., Zheng, Y., & Liu, Y. (2025) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13895 · Cited by 14
Nanodelivery of therapeutic agents in Parkinson's disease
Lafuente, J. V., Requejo, C., & Ugedo, L. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.004 · Cited by 14
FbD Supported Development and In Vitro Evaluation of Carbomer based Resveratrol Loaded Topical Antipsoriatic Nanoemulgel for its Targeted Skin Delivery
Khurana, B., Arora, D., & Narang, R. K. (2020) · Pharmaceutical Nanotechnology · doi:10.2174/2211738508666200129160027 · Cited by 13
Phytonutrients and Technological Development in Formulations
Jahangir, M. A. (2022) · doi:10.31531/jprst.1000159 · Cited by 13
A Comprehensive Review of Nanoemulsion Applications and their Recent Advancements
Das, P., Panda, J. R., Patro, C. N., Sahu, B., & Patnaik, S. S. (2022) · Current Nanomaterials · doi:10.2174/2405461508666221103121439 · Cited by 12
Vitamin-Loaded Nanocarriers as Nutraceuticals in Healthcare Applications
Gupta, M., Aggarwal, R., Raina, N., & Khan, A. (2020) · Springer eBooks · doi:10.1007/978-981-15-1664-1_18 · Cited by 12
Research Progress on Natural Product Ingredients’ Therapeutic Effects on Parkinson’s Disease by Regulating Autophagy
Li, S., Sun, X., Bi, L., Tong, Y., & Liu, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5538200 · Cited by 12
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Nasr, M., Ahmed-Farid, O. A.-H., & Ahmed, R. F. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01162-1 · Cited by 11
Improving bioavailability of nutraceuticals by nanoemulsification
Pund, S., Joshi, A., & Patravale, V. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804305-9.00013-0 · Cited by 11
Antioxidants Against Neurological Disorders
Narang, J. K., Dogra, A., Kaur, T., Narang, R. S., & Singh, A. P. (2024) · Antioxidants · doi:10.1002/9781394270576.ch9 · Cited by 12
Antimicrobial and antibiofilm effects of shikonin with tea tree oil nanoemulsion against Candida albicans and Staphylococcus aureus
Kaur, K., Singh, A., Monga, A., Mohana, P., Khosla, N., & Bedi, N. (2023) · Biofouling · doi:10.1080/08927014.2023.2281511 · Cited by 10
Evaluation of Nanomaterials as Effective Carriers Targeted to Traverse Blood–Brain Barrier for Theragnostics of Neurodegenerative Diseases: An Overview
Vengadesan, D., Arumugam, N., Manikandan, E., & Mandal, A. (2024) · BioNanoScience · doi:10.1007/s12668-024-01773-7 · Cited by 10
Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
Sharma, G., Wadhwa, K., Kumar, S., Singh, G., & Pahwa, R. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01770-z · Cited by 11
Development and Evaluation of Dutasteride Nanoemulgel for the Topical Delivery against Androgenic Alopecia
Alam, M., Mishra, A., Yadav, K. S., Pradhan, D., Kar, B., Ghosh, G., Rath, G., & Rai, V. K. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385269151231031161411 · Cited by 10
Regulatory effects of vitamin E nano-emulsion on blood metabolites, immunological variables, testicular architecture, and sperm ultrastructure of heat-stressed V-line rabbit bucks
El‐Raghi, A. A., Essawi, W. M., Abdelnour, S. A., El-Ratel, I. T., Younis, E. M., Abdel‐Warith, A. A., Hassan, M. A. E., Elhady, M. A., Aboul-Omran, M. A., Neamat‐Allah, A. N. F., et al. (2024) · Italian Journal of Animal Science · doi:10.1080/1828051x.2024.2407081 · Cited by 9
Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer’s disease
Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 8
Phytocompounds and lipid-based drug delivery system for neurodegenerative diseases
Özay, C., & Karpuz, M. (2024) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_455_24 · Cited by 8
Phytomedicine nanoformulations for Parkinson's disease
Saji, C. V., Mohanakumar, K. P., & Shenoi, R. A. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100704 · Cited by 7
Stilbenes Against Alzheimer’s Disease: A Comprehensive Review of Preclinical Studies of Natural and Synthetic Compounds Combined with the Contributions of Developed Nanodrug Delivery Systems
Akkol, E. K., Karatoprak, G. Ş., Dumlupınar, B., Açıkara, Ö. B., Arıcı, R., Yücel, Ç., Aynal, L. C., & Sobarzo‐Sánchez, E. (2025) · Molecules · doi:10.3390/molecules30091982 · Cited by 8
Liposomes as carriers of resveratrol and vitamin E: Evaluating ameliorative antioxidant effect using chemical and cellular test systems
Vanaja, K., Wahl, M., & Heinle, H. (2022) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000680 · Cited by 7
Encapsulation of Functional Plant Oil by Spray Drying: Physicochemical Characterization and Enhanced Anti-Colitis Activity
Zhang, H., Xu, Z., Qiao, Z., Wang, X., Tang, H., Yang, C., & Huang, F. (2022) · Foods · doi:10.3390/foods11192993 · Cited by 7
A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson’s Disease: An Updated Patent and Clinical Trials
Khan, S. A., & Haider, M. F. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273323074241001071645 · Cited by 7
Nose-to Brain Delivery of Resveratrol, a Non-Invasive Method for the Treatment of Cerebral Ischemia
Alquisiras-Burgos, I., González-Herrera, I. G., Alcalá-Alcalá, S., & Aguilera, P. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010007 · Cited by 10
Orally Administered Nanotherapeutics For Parkinson’s Disease: An Old Delivery System Yet More Acceptable
Aggarwal, N., Qamar, Z., Rehman, S., Baboota, S., & Ali, J. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200406072451 · Cited by 7
Self-citation
Nutraceuticals in neurodegenerative diseases
Banerjee, S., Dutta, S., Ghosh, S., & Sil, P. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00017-3 · Cited by 7
Development of novel electrospun nanofibers loaded with Levosulpiride and Cannabidiol encapsulated in cyclodextrin-phospholipid inclusion complex for ameliorated treatment of anxiety and depression
Zai, I., Aqil, M., & Sultana, Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125909 · Cited by 6
Recent progress in nanoparticulate-based intranasal delivery for treating of different central nervous system diseases
Bseiso, E. A., Sheta, N. M., & Abdel-Haleem, K. M. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2409807 · Cited by 6
Bromocriptine mesylate-loaded nanoparticles co-modified with low molecular weight protamine and lactoferrin for enhanced nose-to-brain delivery in Parkinson’s disease treatment
Cong, H., Hu, J., Wang, J., Chang, B., Li, R., Cui, X., Zhang, C., Ji, H., Lin, C., Tang, J., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125054 · Cited by 7
Nose-to-Brain Targeting of Resveratrol Nanoformulations
Bavafa, A., Negah, S. S., & Forouzanfar, F. (2025) · Current Vascular Pharmacology · doi:10.2174/0115701611337079250115071933 · Cited by 7
Increasing resveratrol bioavailability: A therapeutic challenge focusing on the mitochondria
Sandhir, R., Singhal, N. K., & Garg, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00004-8 · Cited by 6
Nanoformulated herbal bioactives for the treatment of neurodegenerative disorders
Sajadimajd, S., Moradi, S. Z., Akbari, V., Aghaz, F., & Farzaei, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824385-5.00008-x · Cited by 6
Uses of nanotechnology in refining the anti-aging activities of plant bioactives
Pandey, B. K., Pandey, K. B., & Srivastava, S. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90581-7.00006-2 · Cited by 8
Phytoconstituents-based nanoformulations for neurodegenerative disorders
Rajput, M. S., Nirmal, N. P., Patel, V. A., Sarkar, P. D., & Raval, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19143-5.00003-7 · Cited by 6
Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route
Ainurofiq, A., Prasetya, A., Rahayu, B. G., Qadri, M. S. A., Kovusov, M., & Laksono, O. E. P. (2023) · Farmacja Polska · doi:10.32383/farmpol/163334 · Cited by 6
Fabrication and characterization of shikonin and sea buckthorn endowed nanoemulsion reinforcing elecrospun scaffolds for treatment of diabetic wounds
Kaur, K., Singh, A., Rajput, N., Bhullar, V., Monga, A., Mahajan, A., Gahlay, G. K., & Bedi, N. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105311 · Cited by 6
A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus
Unnithan, D., Sartaj, A., Iqubal, M. K., Ali, J., & Baboota, S. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2331216 · Cited by 6
Self-citation
Nano-formulation of phytochemicals to combat neurodegenerative diseases: Current and thorough strategies
Chowdhury, S., Kumari, G., & Jit, T. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100249 · Cited by 5
Nanotechnology-Based Plant Antioxidants: A Current Literature Review on Bioavailability and Oxidative Stress
Kılınç, G. E., & Açar, Y. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00689-2 · Cited by 6
Nanotechnology and Parkinson’s disease
Mavridis, I. N., Meliou, M., Pyrgelis, E.-S., & Agapiou, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813667-6.00001-2 · Cited by 5
Lipid nanocarriers encapsulating herbal drugs for brain diseases therapy
Gad, S., El-Gogary, R. I., Geneidi, A. S., & Hathout, R. M. (2023) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2023.202432.1115 · Cited by 5
Nanomedicine for Treating Major Brain Diseases: Advances and Future Directions
Sagar, G., Wilson, B., Mukundan, G. K., Divekar, K., & Jenita⃰, J. J. L. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00277 · Cited by 4
Nanodiagnostics and nanomedicines for neurodegenerative disorders
Sulakhiya, K., Kisku, A., Paliwal, R., Gupta, D., Yadav, Y., Pal, A., & Kumar, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00023-7 · Cited by 4
Recent Advancements in Phyto Component Based Nanocarriers for Improved Treatment of Brain Disorders
Satapathy, B. S., Pattnaik, S., Biswal, S. K., Biswal, B., Sahoo, P. K., Samal, H. B., & Barik, B. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110585 · Cited by 4
Lipid-based Nano-phytomedicines for Disease Treatment and Theranostic Applications
Ali, F., Khasimbi, S., & Ali, A. (2020) · Current Nanomedicine · doi:10.2174/2468187310999201023151700 · Cited by 4
Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment
Hernando, S., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-57696-1_3 · Cited by 4
Surface-engineered chitosan-coated nanostructured lipid carriers for intranasal delivery of Oxcarbazepine and Vitamin E oil in epilepsy management
Haider, F., Aldosari, E., Parveen, R., Baboota, S., Gull, A., Khan, S., & Ali, J. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00855-x · Cited by 5
Self-citation
Polyphenols as Potential Therapeutic Drugs in Neurodegeneration
de Laureto, P. P., Palazzi, L., & Acquasaliente, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89575 · Cited by 3
Nanotherapeutics a promising approach for treatment of Parkinson’s disease
Bhalothia, C., & Nagda, G. (2022) · Materials Today Proceedings · doi:10.1016/j.matpr.2022.10.311 · Cited by 4
Studies of Mucosal Irritation and Cellular Uptake Mechanisms of Xingnaojing Nanoemulsion
Wang, M., Wang, S., Zhang, Y., Liu, H., Li, P., & Du, S. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e20241 · Cited by 3
Nanoemulsion of Ethanolic Extract of Centella asiatica (NanoSECA) Ameliorates Learning and Memory Performance by Enhancing Cholinergic Activities, Increasing Antioxidative Levels, and Attenuating Oxidative Stress Markers in Adult Rats
Jusril, N. A., Mukhtar, S. M., Bakar, S. I. A., Saad, W. M. M., Ng, K. W., & Adenan, M. I. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230831122844 · Cited by 3
Unlocking the Impact of Phyto-bioactive Compounds against Neurodegenerative Disorders
Rahaman, S. M., Ashique, S., Bhowmick, M., Mollick, M., Bhowmick, P., & Kumar, P. (2024) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812320650241015153325 · Cited by 3
Neurodegenerative Disease: Nanotechnology to Rescue
Doke, R. R., Lamkhade, G., Manchare, B. R., & Vinchurkar, K. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_19 · Cited by 3
Synergistic combination of phytotherapeutics for infectious diseases
Kaur, A., & Dang, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820779-6.00006-2 · Cited by 2
Nanotherapeutics of Phytoantioxidants for CNS Disorders
Paul, A., Guha, N., & Zaman, K. (2022) · Wiley eBooks · doi:10.1002/9781119811794.ch20 · Cited by 2
Nanoemulsion through cold emulsification: An advanced cold manufacturing process for a stable and advanced drug delivery system
Bhatt, P., Bhatt, T., Jain, V. K., Jain, R., & Bigoniya, P. (2024) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2024.154558 · Cited by 1
β-Cyclodextrin-functionalized nanocarriers for bromocriptine: development, evaluation and histopathological studies
Waqar, M. A., Khan, I. N., Zahra, S., Shaheen, F., Noureen, S., Ahmad, S., Siddique, M. I., & Alvi, M. N. (2025) · Journal of Microencapsulation · doi:10.1080/02652048.2025.2487034 · Cited by 1
A Comprehensive Review of Nanoemulsion Via the Nose To the Brain in the Management of Parkinson’s Disease
Mahajan, H. S., Sarode, R. J., Deshmane, S. V., Girnar, G., & Khedekar, S. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10170-w · Cited by 1
Expanding the Arsenal of Nanocarriers Against Parkinson Disease: Success so Far Roads Ahead
Devi, N., Dhiman, S., Dora, C. P., Singh, T. G., & Awasthi, A. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03234-0 · Cited by 1
Intranasal delivery of lipid-based nanoparticles for the treatment of neurodegenerative diseases: advances, challenges and future perspectives
Piera, X. M. I., Campo-Montoya, R. D., Cuadrado‐Tejedor, M., García‐Osta, A., Garbayo, E., & Blanco‐Prieto, M. J. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2587903 · Cited by 2
Perfluorocarbon Nanoemulsions for Simultaneous Delivery of Oxygen and Antioxidants During Machine Perfusion Supported Organ Preservation
Patel, S., Pinky, P. P., Das, A. C., Copus, J. S., Aardema, C., Crelli, C. V., Troidle, A., Lambert, E., McCallin, R., Surti, V., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020143 · Cited by 1
Intranasal Nanoemulsion: A Promising Approach for the Management of Parkinson’s Disease
Jurel, P., Bahadur, S., & Bajpai, M. (2024) · Current Nanomaterials · doi:10.2174/0124054615343935240918053255 · Cited by 1
Nutraceutical sector and nanomedicine
Rajendran, K., Dharmaraj, D., Krishnamoorthy, M., Karuppiah, K., & Ethiraj, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820773-4.00014-7 · Cited by 1
Lipid Nanoformulation of Nutraceuticals as Neurotherapeuticals in Neurological Disorders
Taleuzzaman, M., Chauhan, S., Tomar, D. S., Singh, P. K., Talwar, I., & Javed, M. N. (2022) · Wiley eBooks · doi:10.1002/9781119905059.ch7 · Cited by 1
Natural Neuroprotectives for the Management of Parkinson's Disease
Gaba, B., Kumar, S., Md, S., Baboota, S., Narang, J. K., & Ali, J. (2017) · Wiley eBooks · doi:10.1002/9783527803781.ch4
Self-citation
The role of selected antioxidants in the development and treatment of Parkinson’s disease
Markowska, D., Malicka, D., Nuszkiewicz, J., & Szewczyk‐Golec, K. (2019) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0013.5252
Formulation and characterization of topical microemulsion loaded with naproxen
Sakib, S., Verma, V., & Islam, M. U. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.10527
Nanodelivery of Herbal and Phyto‐Antioxidants
Kaya, G., Keskin, M., Keskin, Ş., & Rudrapal, M. (2022) · doi:10.1002/9781119811794.ch7
Intra nasal in-situ gel freighted with Nano naturaceuticals for neurological diseases – from bench to bed side
Yallamalli, I. M., Dommaraju, A. K., & YELLAMELLI, R. (2023) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/22.2.156-170
Recent Advancements in Lipid Nanocarriers for Brain Delivery of Bioactives
Desai, V. M., Mohanty, S., Priya, S., & Singhvi, G. (2024) · Springer eBooks · doi:10.1007/978-981-97-2859-6_5
Molecular Mechanisms Behind Organ-Related Aging and Regulatory Effects of Natural Therapeutics
Abaidullah, R., Ali, S., Summer, M., & Tahir, H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01792-5
Quality by design tailored development of xanthohumol-loaded nanoemulsion: characterization and evaluation of in vitro antioxidant potential
Kumar, G. L. S. S., Harish, V., Mohd, S., Singh, S. K., & Vishwas, S. (2025) · Chemical Papers · doi:10.1007/s11696-025-04260-9
Intranasal Delivery of Natural Compounds: A Promising approach for Parkinson’s Disease therapy
Jadhav, P. D., Velhal, A. B., Redasani, V. K., & Rathod, S. T. (2026) · Asian Journal of Pharmaceutical Research · doi:10.52711/2231-5691.2026.00002
Lyotropic liquid crystalline nanoparticles for multidrug loading involved in neuroprotection and regeneration
Rakotoarisoa, M. (2021) · theses.fr (ABES) · doi:10.70675/7bf6365czfebbz4b3az9400z0a82f6d9364f
Response Surface Methodology-Guided Optimization of Flucytosine Nanoemulsion for Enhanced Antifungal Performance
Tiwari, P., Verma, S., & Saini, G. (2026) · European Pharmaceutical Journal · doi:10.2478/afpuc-2026-0002
Neuroprotective potential of resveratrol in Parkinson, Huntington, amyotrophic lateral sclerosis, and multiple sclerosis: a comprehensive review
Shahsavari, K., Yazarlu, O., Ahmadnia, H., Ardakani, M. T., Khanavi, M., Esfahani, H. M., Abdollahzadeh, R., sajedi, A., Kazemizadeh, H., & Hasanpour, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12300-0
Exploring the potential of resveratrol-enriched cord mesenchymal stem cell derived exosomes in an in vitro Parkinson’s model
Shamshir, S. R. M., Demirbolat, G. M., & Işık, S. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-02003-7

Authors: Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S.
Affiliations: Jamia Hamdard (IN)
Corresponding author: Baboota, Sanjula
ORCID: Pangeni, Rudra
Sharma, Shrestha
Mustafa, Gulam
Ali, Javed
Baboota, Sanjula
Venue: Nanotechnology
Publisher: IOP Publishing
Published: 2014-11-13
Volume: 25
Issue: 48
Pages: 485102
ISSN: 0957-4484 (ISSN-L)
1361-6528
DOI: 10.1088/0957-4484/25/48/485102
OpenAlex: W1967033368
Cited by: 192
References: 32
Citations by year: 2026: 5 · 2025: 18 · 2024: 23 · 2023: 24 · 2022: 22 · 2021: 18 · 2020: 23 · 2019: 18 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 8
FWCI: 5.85
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: iopscience.iop.org/info/page/text-and-data-mining (tdm)
iopscience.iop.org/page/copyright (vor)
Locations: Nanotechnology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: resveratrol, nanoemulsions, Parkinson's disease, vitamin E, brain targeting, intranasal drug delivery, oxidative stress, antioxidant activity, high-pressure homogenization, drug bioavailability, pharmacokinetics, lipid peroxidation, glutathione, superoxide dismutase, malondialdehyde, neuroprotection
MeSH terms: Resveratrol, Animals, Antioxidants, Biological Availability, Brain, Chemistry, Pharmaceutical, Emulsions, Female, Male, Parkinson Disease, Particle Size, Polysorbates, Solubility, Stilbenes, Swine, Viscosity, Vitamin E, Rats, Wistar, Oxidative Stress, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks